Literature DB >> 26410747

A patient with PMP22-related hereditary neuropathy and DBH-gene-related dysautonomia.

Anna Bartoletti-Stella1, Giacomo Chiaro1, Giovanna Calandra-Buonaura1,2, Manuela Contin1,2, Cesa Scaglione2, Giorgio Barletta1,2, Annagrazia Cecere2, Paolo Garagnani3,4,5, Paolo Tieri6, Alberto Ferrarini7, Silvia Piras2, Claudio Franceschi2,4, Massimo Delledonne7, Pietro Cortelli8,9, Sabina Capellari10,11.   

Abstract

Recurrent focal neuropathy with liability to pressure palsies is a relatively frequent autosomal-dominant demyelinating neuropathy linked to peripheral myelin protein 22 (PMP22) gene deletions. The combination of PMP22 gene mutations with other genetic variants is known to cause a more severe phenotype than expected. We present the case of a patient with severe orthostatic hypotension since 12 years of age, who inherited a PMP22 gene deletion from his father. Genetic double trouble was suspected because of selective sympathetic autonomic disturbances. Through exome-sequencing analysis, we identified two novel mutations in the dopamine beta hydroxylase gene. Moreover, with interactome analysis, we excluded a further influence on the origin of the disease by variants in other genes. This case increases the number of unique patients presenting with dopamine-β-hydroxylase deficiency and of cases with genetically proven double trouble. Finding the right, complete diagnosis is crucial to obtain adequate medical care and appropriate genetic counseling.

Entities:  

Keywords:  Dopamine-β-hydroxylase deficiency; Exome sequencing, dysautonomia; Recurrent focal neuropathy with liability to pressure palsies

Mesh:

Substances:

Year:  2015        PMID: 26410747     DOI: 10.1007/s00415-015-7896-z

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  27 in total

1.  MutationTaster evaluates disease-causing potential of sequence alterations.

Authors:  Jana Marie Schwarz; Christian Rödelsperger; Markus Schuelke; Dominik Seelow
Journal:  Nat Methods       Date:  2010-08       Impact factor: 28.547

2.  Monoamine transporters: structure, regulation, and clinical implications.

Authors:  Eduardo E Benarroch
Journal:  Neurology       Date:  2013-07-31       Impact factor: 9.910

Review 3.  Mosaic deletion 11p13 in a child with dopamine beta-hydroxylase deficiency--case report and review of the literature.

Authors:  A Erez; J Li; M T Geraghty; S Ben-Shachar; M L Cooper; D E Mensing; K D Vonalt; Z Ou; A N Pursley; A C Chinault; A Patel; S W Cheung; T Sahoo
Journal:  Am J Med Genet A       Date:  2010-03       Impact factor: 2.802

4.  Isolated noradrenergic failure in adult-onset autosomal dominant leukodystrophy.

Authors:  Pietro Guaraldi; Vincenzo Donadio; Sabina Capellari; Manuela Contin; Maria Chiara Casadio; Pasquale Montagna; Rocco Liguori; Pietro Cortelli
Journal:  Auton Neurosci       Date:  2010-08-16       Impact factor: 3.145

Review 5.  The PMP22 gene and its related diseases.

Authors:  Jun Li; Brett Parker; Colin Martyn; Chandramohan Natarajan; Jiasong Guo
Journal:  Mol Neurobiol       Date:  2012-12-07       Impact factor: 5.590

6.  Congenital dopamine-beta-hydroxylase deficiency. A novel orthostatic syndrome.

Authors:  A J Man in 't Veld; F Boomsma; P Moleman; M A Schalekamp
Journal:  Lancet       Date:  1987-01-24       Impact factor: 79.321

7.  Maximum entropy modeling of short sequence motifs with applications to RNA splicing signals.

Authors:  Gene Yeo; Christopher B Burge
Journal:  J Comput Biol       Date:  2004       Impact factor: 1.479

Review 8.  Patients with congenital dopamine beta-hydroxylase deficiency. A lesson in catecholamine physiology.

Authors:  A Man in 't Veld; F Boomsma; J Lenders; A vd Meiracker; C Julien; J Tulen; P Moleman; T Thien; S Lamberts; M Schalekamp
Journal:  Am J Hypertens       Date:  1988-07       Impact factor: 2.689

9.  Peripartum management of a patient with dopamine beta-hydroxylase deficiency, a rare congenital cause of dysautonomia.

Authors:  N J Scurrah; A W Ross; M Solly
Journal:  Anaesth Intensive Care       Date:  2002-08       Impact factor: 1.669

10.  Predicting the functional, molecular, and phenotypic consequences of amino acid substitutions using hidden Markov models.

Authors:  Hashem A Shihab; Julian Gough; David N Cooper; Peter D Stenson; Gary L A Barker; Keith J Edwards; Ian N M Day; Tom R Gaunt
Journal:  Hum Mutat       Date:  2012-11-02       Impact factor: 4.878

View more
  3 in total

1.  Multiple variants in families with amyotrophic lateral sclerosis and frontotemporal dementia related to C9orf72 repeat expansion: further observations on their oligogenic nature.

Authors:  Maria Pia Giannoccaro; Anna Bartoletti-Stella; Silvia Piras; Annalisa Pession; Patrizia De Massis; Federico Oppi; Michelangelo Stanzani-Maserati; Elena Pasini; Simone Baiardi; Patrizia Avoni; Piero Parchi; Rocco Liguori; Sabina Capellari
Journal:  J Neurol       Date:  2017-06-15       Impact factor: 4.849

Review 2.  Clinical presentation and long-term follow-up of dopamine beta hydroxylase deficiency.

Authors:  Tessa Wassenberg; Jaap Deinum; Frans J van Ittersum; Erik-Jan Kamsteeg; Maartje Pennings; Marcel M Verbeek; Ron A Wevers; Mirjam E van Albada; Ido P Kema; Jorie Versmissen; Ton van den Meiracker; Jacques W M Lenders; Leo Monnens; Michèl A Willemsen
Journal:  J Inherit Metab Dis       Date:  2020-10-15       Impact factor: 4.982

3.  A "Triple Trouble" Case of Facioscapulohumeral Muscular Dystrophy Accompanied by Peripheral Neuropathy and Myoclonic Epilepsy.

Authors:  Xiao-Dan Lin; Jun-Jie He; Feng Lin; Hai-Zhu Chen; Liu-Qing Xu; Wei Hu; Nai-Qing Cai; Min-Ting Lin; Ning Wang; Zhi-Qiang Wang; Guo-Rong Xu
Journal:  Chin Med J (Engl)       Date:  2018-09-20       Impact factor: 2.628

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.